A retrospective multicenter cohort study to determine safety and efficacy of calcitonin gene–related peptide monoclonal antibody treatment in adolescents with chronic headache disorders
Latest Information Update: 01 Dec 2021
At a glance
- Drugs Erenumab (Primary) ; Fremanezumab (Primary) ; Galcanezumab (Primary)
- Indications Headache disorders; Migraine; Migraine with aura
- Focus Adverse reactions; Therapeutic Use
- 01 Dec 2021 New trial record